ASCO submits proposals on CPT code changes for infused drugs

The American Society of Clinical Oncology has submitted a series of proposals to an AMA workgroup aimed at changing a number of CPT codes for infused drugs.

Related Content:

Practice Management

Urology Times Money Matters: Alternative Investments

What can be learned from CMS data on health care spending?

FDA finalizes blueprint for cancer drug trials involving patients with CNS metastases